Immuno-Oncology 360

IO360˚convenes stakeholders spanning the science and business communities to report on the latest data impacting immuno-oncology to fight a wider range of cancers.

The 7th Annual Immuno-Oncology 360° Delivers Three Key Benefits:

• Access to KOLs driving the science
• Partnership opportunities with all stakeholders in Immuno-Oncology
• Presentations on the latest data affecting the science, clinical and business advancements in Immuno-Oncology

Parexel presentation 
Wednesday, February 24 ~ 3:15pm
Translating Biomarkers into Precision Immuno-Oncology Therapy Development

• Recent data on current and emerging IO biomarkers that guide treatment selection across tumor types
• Challenges and limitations associated with current and emerging biomarkers in patient selection for IO trials and therapies
• Strategic and operational considerations to incorporate biomarker testing including biopsy sampling, testing platforms, and interpretation

Speaker: Angela Qu, Vice President, Genomic Medicine

Use the code: PAREX10 to receive 10% off your registration.